Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on December 12, 2002; DOI 10.1182/blood-2002-08-2477.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-08-2477v1
101/8/3074    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kubota, R.
Right arrow Articles by Osame, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kubota, R.
Right arrow Articles by Osame, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted August 19, 2002
Accepted December 2, 2002

Degenerate specificity of HTLV-I-specific CD8+ T cells during viral replication in patients with HTLV-I-associated myelopathy (HAM/TSP)

Ryuji Kubota*, Yoshitaka Furukawa, Shuji Izumo, Koichiro Usuku, and Mitsuhiro Osame

The Third Department of Internal Medicine, Faculty of Medicine, Kagoshima University, Kagoshima, Japan
Center for Chronic Viral Diseases, Faculty of Medicine, Kagoshima University, Kagoshima, Japan
Department of Medical Informatics, Faculty of Medicine, Kagoshima University, Kagoshima, Japan

* Corresponding author; email: kubotar{at}m2.kufm.kagoshima-u.ac.jp.

Human T lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an inflammatory neurological disease caused by HTLV-I infection, in which HTLV-I-infected CD4+ T cells and HTLV-I-specific CD8+ T cells may play a role in the disease pathogenesis. Patients with HAM/TSP have high proviral loads despite vigorous virus-specific CD8+ T cell responses; however, it is unknown whether the T cells are efficient in eliminating the virus in vivo. To define the dynamics of HTLV-I-specific CD8+ T cell responses, we have investigated longitudinal alterations in HTLV-I proviral load, amino acid changes in an immunodominant viral epitope, frequency of HTLV-I-specific T cells, and degeneracy of T cell recognition in patients with HAM/TSP. We showed that the frequency and the degeneracy of the HTLV-I-specific CD8+ T cells correlated well with proviral load in the longitudinal study. The proviral load was much higher in a patient with low degeneracy of HTLV-I-specific T cells, compared to a patient with comparable frequency but higher degeneracy of the T cells. Furthermore, in a larger number of patients divided into two groups by the proviral load, those with high proviral load had lower degeneracy of T cell recognition than those with low proviral load. Sequencing analysis revealed that epitope mutations were remarkably increased in a patient when the frequency and degeneracy were at the lowest. These data suggest that HTLV-I-specific CD8+ T cells with degenerate specificity are increased during viral replication, and control the viral infection.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
R. Fukumoto, M. Dundr, C. Nicot, A. Adams, V. W. Valeri, L. E. Samelson, and G. Franchini
Inhibition of T-Cell Receptor Signal Transduction and Viral Expression by the Linker for Activation of T Cells-Interacting p12I Protein of Human T-Cell Leukemia/Lymphoma Virus Type 1
J. Virol., September 1, 2007; 81(17): 9088 - 9099.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Kubota, K. Hanada, Y. Furukawa, K. Arimura, M. Osame, T. Gojobori, and S. Izumo
Genetic Stability of Human T Lymphotropic Virus Type I despite Antiviral Pressures by CTLs
J. Immunol., May 1, 2007; 178(9): 5966 - 5972.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020